Teladoc (TDOC) PT Raised to $68 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Teladoc (TDOC) PT Raised to $86 at Chardan Capital Markets
August 3, 2018 6:39 AM EDTChardan Capital Markets raised its price target on Teladoc (NYSE: TDOC) to $86.00 (from $73.00) while maintaining a Buy rating.
Analyst Steven Wardell commented, "After market close on Wed., TDOC reported revenue and earnings that beat "consensus, and raised its 2018 guide. TDOCs... More
Teladoc (TDOC) PT Raised to $52 at Cantor Fitzgerald Following 2Q
August 2, 2018 8:21 AM EDTCantor Fitzgerald raised its price target on Teladoc (NYSE: TDOC) to $52.00 (from $50.00) while maintaining a Neutral rating following the company's 2Q release. Revenue was $94.6 million vs. consensus of $92M. U.S. paid visits grew 41%.
Given the strong growth and including Advance Medical, TDOC... More
Teladoc (TDOC) PT Raised to $77 at Piper Jaffray Following 2Q Report
August 2, 2018 7:13 AM EDTPiper Jaffray raised its price target on Teladoc (NYSE: TDOC) to $77.00 (from $55.00) while maintaining an Overweight rating following the company's 2Q earnings report. Total revenue of $94.6M was up 112% on an absolute basis and 39% organically, and beat Consensus estimates of $91.9M. EBITDA of... More
Teladoc (TDOC) PT Raised to $74 at KeyBanc
August 2, 2018 5:12 AM EDTKeyBanc raised its price target on Teladoc (NYSE: TDOC) to $74.00 (from $70.00) while maintaining a Overweight rating.
... MoreTeladoc (TDOC) Misses Q2 EPS by 3c, Revenues Beat; Guides Revs Above
August 1, 2018 4:07 PM EDTTeladoc (NYSE: TDOC) reported Q2 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $94.6 million versus the consensus estimate of $92.37 million.
GUIDANCE:
Teladoc sees Q3 2018 revenue of $106-108 million, versus the consensus of $105.1... More
